Moderna (MRNA) News Today $25.49 -0.41 (-1.59%) As of 02:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Rakuten Securities Inc. Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA)Rakuten Securities Inc. raised its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 248.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,160 shares of the company's stock after buying an additional 18June 17, 2025 | marketbeat.comModerna, Inc. (MRNA) Presents at Barclays Speaking the Science Call Series TranscriptJune 16, 2025 | seekingalpha.comModerna (NASDAQ:MRNA) Stock Price Down 3.8% - Here's What HappenedModerna (NASDAQ:MRNA) Trading Down 3.8% - Time to Sell?June 16, 2025 | marketbeat.comBarclays Speaking the Science Call SeriesJune 16, 2025 | seekingalpha.com27,611 Shares in Moderna, Inc. (NASDAQ:MRNA) Purchased by BDF GestionBDF Gestion acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,611 shares of the company's stock, valuedJune 16, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC cut its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 35.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 71,395 shares of the company's stock after selling 38June 16, 2025 | marketbeat.comCelebrated, then disparaged: mRNA’s promise is tarnished under TrumpJune 14, 2025 | msn.comInvestors Purchase High Volume of Moderna Call Options (NASDAQ:MRNA)Moderna, Inc. (NASDAQ:MRNA - Get Free Report) was the recipient of unusually large options trading on Friday. Stock investors acquired 151,646 call options on the stock. This represents an increase of 74% compared to the average volume of 87,062 call options.June 14, 2025 | marketbeat.comFDA expands approval of Moderna's RSV vaccine to some adults under age 60June 13, 2025 | msn.comFDA approves expanded use of Moderna’s RSV shot, but uncertainty remainsJune 13, 2025 | msn.comModerna falls on doubts over new CDC panel's backing of RSV vaccineJune 13, 2025 | msn.comHHS Misleads on mRNA Vaccine Safety After Pulling Moderna FundingJune 13, 2025 | msn.comModerna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospectsJune 13, 2025 | reuters.comModerna’s RSV Vaccine Gets FDA Nod For Younger At-Risk Adults: Retail Stays Guarded Amid RFK Jr’s Immunization Shake-UpJune 13, 2025 | msn.comFDA expands Moderna's RSV vaccine approval to at-risk adultsJune 13, 2025 | msn.comTobam Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA)Tobam increased its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 75.2% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,753 shares of the company's stock after buying an additional 19,208 shares during the period. TobamJune 13, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Sold by Union Bancaire Privee UBP SAUnion Bancaire Privee UBP SA trimmed its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 42.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 22,015 shares of the company's stock after selling 15,June 13, 2025 | marketbeat.comUS FDA approves expanded use of Moderna's RSV vaccine for at-risk adultsJune 12, 2025 | reuters.comIs it Time to Dump Your Shares of Moderna?June 12, 2025 | fool.comModerna, Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptJune 11, 2025 | seekingalpha.comLarge cohort study reassures on mRNA vaccine safety for early pregnanciesJune 11, 2025 | msn.comRFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts sayJune 10, 2025 | cnbc.comWhy Trump turned against ‘gold standard’ mRNA vaccinesJune 10, 2025 | msn.comWhat Sparked Moderna Stock Crash?June 10, 2025 | forbes.comWhy Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.June 10, 2025 | barrons.comGAMMA Investing LLC Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA)GAMMA Investing LLC grew its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 6,981.7% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 224,702 shares of the company's stock after buying an additional 221,529 shares during the period. GAMMA InvestingJune 10, 2025 | marketbeat.comVaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.June 9, 2025 | investors.comTB Alternative Assets Ltd. Acquires Shares of 652,373 Moderna, Inc. (NASDAQ:MRNA)TB Alternative Assets Ltd. acquired a new stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 652,373 shares of the company's stock, valuJune 8, 2025 | marketbeat.comRhumbline Advisers Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Rhumbline Advisers increased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 13.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 597,467 shares of the company's stock after purchasing an additional 72,46June 8, 2025 | marketbeat.comIn axing mRNA contracts, Trump delivers another blow to U.S. biosecurity, former officials sayJune 6, 2025 | msn.comIn axing mRNA contract, Trump delivers another blow to US biosecurity, former officials sayJune 6, 2025 | abcnews.go.comModerna, Inc. (NASDAQ:MRNA) Given Average Recommendation of "Hold" by BrokeragesShares of Moderna, Inc. (NASDAQ:MRNA - Get Free Report) have been assigned a consensus rating of "Hold" from the twenty-three ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell rating, fifteen have issued a holJune 6, 2025 | marketbeat.comUsed in Covid Shots, mRNA May Help Rid the Body of H.I.V.June 5, 2025 | nytimes.comModerna, Inc. (MRNA) Presents at Jefferies Global Healthcare Conference TranscriptJune 5, 2025 | seekingalpha.comRFK Jr. says Moderna agreed to another clinical trial to support new COVID shotJune 4, 2025 | msn.comUS appeals court sides with Moderna on COVID patent claimsJune 4, 2025 | reuters.comAlpha Wealth Funds LLC Buys Shares of 15,000 Moderna, Inc. (NASDAQ:MRNA)Alpha Wealth Funds LLC purchased a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,000 shares of the company's stock, valued at approximately $425,000June 4, 2025 | marketbeat.comModerna Stock Climbs as FDA Approves New COVID-19 VaccineJune 4, 2025 | msn.comDown 80%, Should You Buy the Dip on Moderna?June 4, 2025 | fool.comModerna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy saysJune 3, 2025 | reuters.comModerna's (MRNA) "Market Perform" Rating Reaffirmed at William BlairWilliam Blair restated a "market perform" rating on shares of Moderna in a research report on Monday.June 3, 2025 | marketbeat.comLVW Advisors LLC Invests $298,000 in Moderna, Inc. (NASDAQ:MRNA)LVW Advisors LLC bought a new position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 10,500 shares of the company's stock, valued at approximately $29June 3, 2025 | marketbeat.comHow Moderna Went From Pandemic Hero to Vaccine VictimJune 2, 2025 | msn.comModerna, favored by the first Trump administration for its Covid-19 vaccine, is now in trouble as Trump 2.0 shifts its position on vaccine-makingJune 2, 2025 | wsj.comModerna (MRNA) Faces Multiple Regulatory ChallengesJune 2, 2025 | msn.comModerna: Vaccine Approval (Finally!) Provides A Reason To Be CheerfulJune 2, 2025 | seekingalpha.comModerna Stock Is Trading Higher Monday: What's Going On?June 2, 2025 | benzinga.comTop Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and MoreJune 2, 2025 | investopedia.comModerna moves higher on FDA approval of new COVID-19 vaccineJune 2, 2025 | proactiveinvestors.comModerna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk IndividualsJune 2, 2025 | benzinga.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.610.65▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼425▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Dr. Reddy's Laboratories News Ascendis Pharma A/S News Qiagen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRNA Stock Free MRNA Stock Alerts